tiprankstipranks

Salter Malcolm Insider Profile

4 Followers
Salter Malcolm, Director at C4 Therapeutics, holds 15.99K shares in C4 Therapeutics (Ticker: CCCC).
tipranks
Salter Malcolm

Salter Malcolm
C4 Therapeutics (CCCC)
Director

Not Ranked
Salter Malcolm has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$574K
100.00%
A breakdown of Salter Malcolm's holdings

Insider Roles

C4 Therapeutics
(CCCC)
Director
Roles that Salter Malcolm holds in companies

Most Profitable Insider Trade

Stock:
C4 Therapeutics
(CCCC)
Rating:Informative Buy
Date:Oct 06, 2020 - Oct 06, 2021
Return:+33.00%
The most profitable trade made by Salter Malcolm

Salter Malcolm's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
C4 Therapeutics
Oct 06, 2020
Director
Uninformative Buy
$573.70K
Success Rate for
CCCC
1 out of 1 profitable transactions on
CCCC
100%
Average Return for
CCCC
Average return per transaction on
CCCC
+33.00%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 06, 2020
Uninformative Buy
$0.00
-
$0.00
Oct 06, 2020
Informative Buy
$24.98K
-
$19.00
+33.00%
List of latest transactions for each holding click on a transaction to see Salter Malcolm's performance on stock

Salter Malcolm insider profile FAQ

What is the percentage of profitable transactions made by Salter Malcolm?
The percentage of profitable transactions made by Salter Malcolm is ―.
    What is the average return per transaction made by Salter Malcolm?
    The average return per transaction made by Salter Malcolm is ―.
      What stocks does Salter Malcolm hold?
      Salter Malcolm holds: CCCC stocks.
        What was Salter Malcolm’s latest transaction?
        Salter Malcolm latest transaction was an Uninformative Buy of ―.
          What was Salter Malcolm's most profitable transaction?
          Salter Malcolm’s most profitable transaction was an Informative Buy of CCCC stock on October 6, 2020. The return on the trade was 33.00%.
            What is Salter Malcolm's role in C4 Therapeutics?
            Salter Malcolm's role in C4 Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.